Ali Javaheri, MD
Advanced Heart Failure and Transplant Cardiology · Saint Louis, MONPI 1740449354
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $2,838 of the $4,198 with a category attached, or 67.6%. Pfizer accounts for 67.6% of it on its own, with 4 other manufacturers making up the rest. Reporting peaked in 2023 at $2,558 and has fallen 98.3% since, to $43 in 2025. That places this record below the midpoint for advanced heart failure and transplant cardiology clinicians in MO, where the typical reported total is $7,967.
Across 21 payments — averaging $199.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$3K
- Abbott$814
- Abiomed$293
- Biosense Webster, Inc.$128
- Actelion Pharmaceuticals US, Inc.$125
Across 4 payments — averaging $29,062 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Astrazeneca AB$60K
- AstraZeneca$52K
- Pfizer$4K
What the payments were for
- Travel & lodging$2,83868%
- Food & beverage$1,36032%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 4 | $2,838 |
| Abbott | 13 | $814 |
| Abiomed | 2 | $293 |
| Biosense Webster, Inc. | 1 | $128 |
| Actelion Pharmaceuticals US, Inc. | 1 | $125 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,198 in reported general payments places this provider in the 35th percentile of 26 advanced heart failure and transplant cardiology providers in Missouri.
See all advanced heart failure and transplant cardiology providers in Missouri →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other advanced heart failure and transplant cardiology in Saint Louis
- Gregory EwaldSaint Louis$35K
- Sumanth PrabhuSaint Louis$35K
- Nancy SweitzerSaint Louis$32K
- Justin HartupeeSaint Louis$30K
- Kory LavineSaint Louis$12K
- Justin VaderSaint Louis$8K
- Jonathan MorenoSaint Louis$5K
- Amanda VermaSaint Louis$5K
- Edward GeltmanSaint Louis$4K
- Joel SchillingSaint Louis$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.